XBiotech

$8.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.45 (-5.23%) As of 2:55 PM EDT today
-$0.45 (-5.23%) Today

Why Robinhood?

You can buy or sell XBiotech and other stocks, options, ETFs, and crypto commission-free!

About XBIT

XBiotech Inc. Common Stock, also called XBiotech, is a biopharmaceutical company, which engages in development and commercialization of therapeutic antibodies based on its True Human™ proprietary technology. Read More Its product pipeline include oncology, infectious diseases, dermatology, and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.

Employees
53
Headquarters
Austin, Texas
Founded
2005
Market Cap
352.69M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
162.90K
High Today
$8.71
Low Today
$8.08
Open Price
$8.65
Volume
102.60K
52 Week High
$11.74
52 Week Low
$2.13

Collections

XBIT Earnings

-$0.20
-$0.17
-$0.14
-$0.11
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.15 per share
Actual
Expected Aug 26, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.